Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Joseph Catanzaro is an analyst at Piper Sandler. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/20/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 02/28/2025 | IOVA | Buy Now | Iovance Biotherapeutics | $3.59 | 67.13% | Joseph Catanzaro42% | $7.5 → $6 | Maintains | Neutral | Get Alert |
| 02/27/2025 | SDGR | Buy Now | Schrodinger | $22.51 | 99.91% | Joseph Catanzaro42% | $50 → $45 | Maintains | Overweight | Get Alert |
| 02/13/2025 | MRUS | Buy Now | Merus | $47.00 | 78.72% | Joseph Catanzaro42% | → $84 | Initiates | → Overweight | Get Alert |
| 02/12/2025 | GILD | Buy Now | Gilead Sciences | $107.75 | 2.09% | Joseph Catanzaro42% | $105 → $110 | Maintains | Overweight | Get Alert |
| 02/12/2025 | EXEL | Buy Now | Exelixis | $37.05 | 2.56% | Joseph Catanzaro42% | $37 → $38 | Maintains | Overweight | Get Alert |
| 01/31/2025 | IOVA | Buy Now | Iovance Biotherapeutics | $3.59 | 108.91% | Joseph Catanzaro42% | $10 → $7.5 | Maintains | Neutral | Get Alert |
| 01/17/2025 | KROS | Buy Now | Keros Therapeutics | $11.42 | 31.35% | Joseph Catanzaro42% | $40 → $15 | Maintains | Overweight | Get Alert |
| 01/13/2025 | EXEL | Buy Now | Exelixis | $37.05 | -0.13% | Joseph Catanzaro42% | $36 → $37 | Maintains | Overweight | Get Alert |
| 01/10/2025 | HALO | Buy Now | Halozyme Therapeutics | $64.55 | -17.89% | Joseph Catanzaro42% | $52 → $53 | Maintains | Neutral | Get Alert |
| 12/13/2024 | CRDF | Buy Now | Cardiff Oncology | $3.90 | 156.41% | Joseph Catanzaro42% | $7 → $10 | Maintains | Overweight | Get Alert |
| 11/07/2024 | RVMD | Buy Now | Revolution Medicines | $38.75 | 80.65% | Joseph Catanzaro42% | $57 → $70 | Maintains | Overweight | Get Alert |
| 11/07/2024 | GILD | Buy Now | Gilead Sciences | $107.75 | -2.55% | Joseph Catanzaro42% | $95 → $105 | Maintains | Overweight | Get Alert |
| 11/04/2024 | HALO | Buy Now | Halozyme Therapeutics | $64.55 | -19.44% | Joseph Catanzaro42% | $51 → $52 | Maintains | Neutral | Get Alert |
| 11/04/2024 | EPIX | Buy Now | ESSA Pharma | $1.61 | 24.22% | Joseph Catanzaro42% | $15 → $2 | Downgrade | Overweight → Neutral | Get Alert |
| 10/31/2024 | BMEA | Buy Now | Biomea Fusion | $2.59 | 633.17% | Joseph Catanzaro42% | $10 → $19 | Maintains | Overweight | Get Alert |
| 10/30/2024 | EXEL | Buy Now | Exelixis | $37.05 | -2.83% | Joseph Catanzaro42% | $33 → $36 | Maintains | Overweight | Get Alert |
| 10/07/2024 | IMTX | Buy Now | Immatics | $5.37 | 253.82% | Joseph Catanzaro42% | → $19 | Initiates | → Overweight | Get Alert |
| 09/23/2024 | BDTX | Buy Now | Black Diamond Therapeutic | $1.77 | 747.46% | Joseph Catanzaro42% | $12 → $15 | Maintains | Overweight | Get Alert |
| 09/11/2024 | GILD | Buy Now | Gilead Sciences | $107.75 | -11.83% | Joseph Catanzaro42% | $95 → $95 | Maintains | Overweight | Get Alert |
| 08/27/2024 | AADI | Buy Now | Aadi Bioscience | $2.06 | -15.05% | Joseph Catanzaro42% | $5 → $1.75 | Downgrade | Overweight → Neutral | Get Alert |
| 08/19/2024 | TSBX | Buy Now | Turnstone Biologics | $0.39 | 851.78% | Joseph Catanzaro42% | $20 → $3.75 | Maintains | Overweight | Get Alert |
| 08/19/2024 | IBRX | Buy Now | ImmunityBio | $2.77 | 71.48% | Joseph Catanzaro42% | $6 → $4.75 | Maintains | Neutral | Get Alert |
| 08/15/2024 | LENZ | Buy Now | LENZ Therapeutics | $24.00 | 50% | Joseph Catanzaro42% | $36 → $36 | Maintains | Overweight | Get Alert |
| 07/29/2024 | IOVA | Buy Now | Iovance Biotherapeutics | $3.59 | 178.55% | Joseph Catanzaro42% | $19 → $10 | Downgrade | Overweight → Neutral | Get Alert |
| 07/08/2024 | DAWN | Buy Now | Day One Biopharmaceutical | $8.28 | 383.09% | Joseph Catanzaro42% | $40 → $40 | Maintains | Overweight | Get Alert |
| 07/03/2024 | BDTX | Buy Now | Black Diamond Therapeutic | $1.77 | 577.97% | Joseph Catanzaro42% | $12 → $12 | Maintains | Overweight | Get Alert |
| 06/14/2024 | OCUL | Buy Now | Ocular Therapeutix | $7.75 | 93.55% | Joseph Catanzaro42% | $15 → $15 | Maintains | Overweight | Get Alert |
| 06/07/2024 | BMEA | Buy Now | Biomea Fusion | $2.59 | 285.88% | Joseph Catanzaro42% | $45 → $10 | Maintains | Overweight | Get Alert |
| 06/07/2024 | HALO | Buy Now | Halozyme Therapeutics | $64.55 | -20.99% | Joseph Catanzaro42% | $48 → $51 | Downgrade | Overweight → Neutral | Get Alert |
| 06/05/2024 | NRIX | Buy Now | Nurix Therapeutics | $13.90 | 151.8% | Joseph Catanzaro42% | $35 → $35 | Maintains | Overweight | Get Alert |
| 05/28/2024 | CTMX | Buy Now | CytomX Therapeutics | $0.66 | 430.3% | Joseph Catanzaro42% | $2.25 → $3.5 | Upgrade | Neutral → Overweight | Get Alert |
| 05/16/2024 | CNTX | Buy Now | Context Therapeutics | $0.81 | 455.56% | Joseph Catanzaro42% | → $4.5 | Initiates | → Overweight | Get Alert |
| 04/29/2024 | IBRX | Buy Now | ImmunityBio | $2.77 | 116.61% | Joseph Catanzaro42% | $5 → $6 | Maintains | Neutral | Get Alert |
| 04/25/2024 | ACRV | Buy Now | Acrivon Therapeutics | $5.46 | 449.45% | Joseph Catanzaro42% | $26 → $30 | Maintains | Overweight | Get Alert |
| 04/22/2024 | BOLD | Buy Now | Boundless Bio | $1.57 | 1173.89% | Joseph Catanzaro42% | → $20 | Initiates | → Overweight | Get Alert |
| 04/05/2024 | ACHL | Buy Now | Achilles Therapeutics | $1.44 | 38.79% | Joseph Catanzaro42% | $8 → $2 | Downgrade | Overweight → Neutral | Get Alert |
| 03/27/2024 | KROS | Buy Now | Keros Therapeutics | $11.42 | 819.44% | Joseph Catanzaro42% | → $105 | Maintains | Overweight | Get Alert |
| 03/27/2024 | LENZ | Buy Now | LENZ Therapeutics | $24.00 | 16.67% | Joseph Catanzaro42% | → $28 | Initiates | → Overweight | Get Alert |
| 03/26/2024 | DAWN | Buy Now | Day One Biopharmaceutical | $8.28 | 383.09% | Joseph Catanzaro42% | $40 → $40 | Maintains | Overweight | Get Alert |
| 03/25/2024 | IBRX | Buy Now | ImmunityBio | $2.77 | 80.51% | Joseph Catanzaro42% | $4 → $5 | Maintains | Neutral | Get Alert |
| 03/18/2024 | IMAB | Buy Now | I-MAB | $0.84 | 1093.32% | Joseph Catanzaro42% | $15 → $10 | Maintains | Overweight | Get Alert |
| 03/14/2024 | IOVA | Buy Now | Iovance Biotherapeutics | $3.59 | 429.25% | Joseph Catanzaro42% | $18 → $19 | Maintains | Overweight | Get Alert |
| 03/11/2024 | RVMD | Buy Now | Revolution Medicines | $38.75 | 10.97% | Joseph Catanzaro42% | → $43 | Initiates | → Overweight | Get Alert |
| 03/01/2024 | CRDF | Buy Now | Cardiff Oncology | $3.90 | 79.49% | Joseph Catanzaro42% | $5 → $7 | Maintains | Overweight | Get Alert |
| 02/29/2024 | SDGR | Buy Now | Schrodinger | $22.51 | 122.12% | Joseph Catanzaro42% | $60 → $50 | Maintains | Overweight | Get Alert |
| 02/28/2024 | DAWN | Buy Now | Day One Biopharmaceutical | $8.28 | 383.09% | Joseph Catanzaro42% | $45 → $40 | Maintains | Overweight | Get Alert |
| 02/26/2024 | OCUL | Buy Now | Ocular Therapeutix | $7.75 | 93.55% | Joseph Catanzaro42% | $10 → $15 | Maintains | Overweight | Get Alert |
| 02/20/2024 | IOVA | Buy Now | Iovance Biotherapeutics | $3.59 | 401.39% | Joseph Catanzaro42% | $14 → $18 | Maintains | Overweight | Get Alert |
| 02/12/2024 | TNGX | Buy Now | Tango Therapeutics | $1.68 | 971.43% | Joseph Catanzaro42% | → $18 | Initiates | → Overweight | Get Alert |
| 12/27/2023 | GRCL | Buy Now | Gracell Biotechnologies | — | — | Joseph Catanzaro42% | → $10 | Downgrade | Overweight → Neutral | Get Alert |
| 12/15/2023 | AADI | Buy Now | Aadi Bioscience | $2.06 | 142.72% | Joseph Catanzaro42% | $30 → $5 | Maintains | Overweight | Get Alert |
| 12/04/2023 | IMGN | Buy Now | Immunogen | — | — | Joseph Catanzaro42% | $24 → $31 | Downgrade | Overweight → Neutral | Get Alert |
| 10/16/2023 | RPTX | Buy Now | Repare Therapeutics | $1.11 | 2152.25% | Joseph Catanzaro42% | $30 → $25 | Maintains | Overweight | Get Alert |
| 10/10/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | Joseph Catanzaro42% | → $58 | Downgrade | Overweight → Neutral | Get Alert |
| 08/15/2023 | TSBX | Buy Now | Turnstone Biologics | $0.39 | 4976.14% | Joseph Catanzaro42% | → $20 | Initiates | → Overweight | Get Alert |
| 07/24/2023 | GILD | Buy Now | Gilead Sciences | $107.75 | -7.19% | Joseph Catanzaro42% | $105 → $100 | Maintains | Overweight | Get Alert |
| 07/14/2023 | BDTX | Buy Now | Black Diamond Therapeutic | $1.77 | 521.47% | Joseph Catanzaro42% | → $11 | Initiates | → Overweight | Get Alert |
| 06/26/2023 | BMEA | Buy Now | Biomea Fusion | $2.59 | 1636.45% | Joseph Catanzaro42% | $40 → $45 | Maintains | Overweight | Get Alert |
| 05/23/2023 | RAIN | Buy Now | Rain Oncology | $1.95 | -10.26% | Joseph Catanzaro42% | $15 → $1.75 | Downgrade | Overweight → Neutral | Get Alert |
| 05/12/2023 | IBRX | Buy Now | ImmunityBio | $2.77 | 44.4% | Joseph Catanzaro42% | $10 → $4 | Downgrade | Overweight → Neutral | Get Alert |
| 05/10/2023 | EXEL | Buy Now | Exelixis | $37.05 | -24.43% | Joseph Catanzaro42% | → $28 | Assumes | → Overweight | Get Alert |
| 05/10/2023 | HALO | Buy Now | Halozyme Therapeutics | $64.55 | -28.74% | Joseph Catanzaro42% | → $46 | Upgrade | Neutral → Overweight | Get Alert |
| 05/05/2023 | SDGR | Buy Now | Schrodinger | $22.51 | 166.55% | Joseph Catanzaro42% | → $60 | Assumes | → Overweight | Get Alert |
| 05/05/2023 | KROS | Buy Now | Keros Therapeutics | $11.42 | 863.22% | Joseph Catanzaro42% | $120 → $110 | Maintains | Overweight | Get Alert |
| 05/03/2023 | IMGN | Buy Now | Immunogen | — | — | Joseph Catanzaro42% | $6 → $16 | Upgrade | Neutral → Overweight | Get Alert |
| 04/28/2023 | GILD | Buy Now | Gilead Sciences | $107.75 | -2.55% | Joseph Catanzaro42% | → $105 | Assumes | → Overweight | Get Alert |
| 04/03/2023 | IMAB | Buy Now | I-MAB | $0.84 | 2883.29% | Joseph Catanzaro42% | $30 → $25 | Maintains | Overweight | Get Alert |
| 03/28/2023 | BMEA | Buy Now | Biomea Fusion | $2.59 | 1443.51% | Joseph Catanzaro42% | $16 → $40 | Maintains | Overweight | Get Alert |
| 01/27/2023 | IOVA | Buy Now | Iovance Biotherapeutics | $3.59 | 289.97% | Joseph Catanzaro42% | $11 → $14 | Upgrade | Neutral → Overweight | Get Alert |
| 01/09/2023 | DAWN | Buy Now | Day One Biopharmaceutical | $8.28 | 443.48% | Joseph Catanzaro42% | $40 → $45 | Maintains | Overweight | Get Alert |
| 12/20/2022 | CPRX | Buy Now | Catalyst Pharmaceuticals | $22.70 | -11.89% | Joseph Catanzaro42% | $18 → $20 | Maintains | Overweight | Get Alert |
| 12/12/2022 | ACRV | Buy Now | Acrivon Therapeutics | $5.46 | 357.88% | Joseph Catanzaro42% | → $25 | Initiates | → Overweight | Get Alert |
| 12/07/2022 | ACHL | Buy Now | Achilles Therapeutics | $1.44 | 455.17% | Joseph Catanzaro42% | $10 → $8 | Maintains | Overweight | Get Alert |
| 11/21/2022 | IOVA | Buy Now | Iovance Biotherapeutics | $3.59 | 206.41% | Joseph Catanzaro42% | $13 → $11 | Maintains | Neutral | Get Alert |
| 11/08/2022 | OYST | Buy Now | Oyster Point Pharma | — | — | Joseph Catanzaro42% | $15 → $11 | Downgrade | Overweight → Neutral | Get Alert |
| 09/13/2022 | CRDF | Buy Now | Cardiff Oncology | $3.90 | 28.21% | Joseph Catanzaro42% | $7 → $5 | Maintains | Overweight | Get Alert |
| 08/30/2022 | IMAB | Buy Now | I-MAB | $0.84 | 3479.95% | Joseph Catanzaro42% | $35 → $30 | Maintains | Overweight | Get Alert |
| 08/11/2022 | HARP | Buy Now | Harpoon Therapeutics | — | — | Joseph Catanzaro42% | $90 → $70 | Maintains | Overweight | Get Alert |
| 07/07/2022 | CTMX | Buy Now | CytomX Therapeutics | $0.66 | 127.27% | Joseph Catanzaro42% | $10 → $1.5 | Downgrade | Overweight → Neutral | Get Alert |
| 06/21/2022 | DAWN | Buy Now | Day One Biopharmaceutical | $8.28 | 383.09% | Joseph Catanzaro42% | $35 → $40 | Maintains | Overweight | Get Alert |
| 06/02/2022 | RPTX | Buy Now | Repare Therapeutics | $1.11 | 2602.7% | Joseph Catanzaro42% | $25 → $30 | Maintains | Overweight | Get Alert |
| 05/27/2022 | IOVA | Buy Now | Iovance Biotherapeutics | $3.59 | 262.12% | Joseph Catanzaro42% | $20 → $13 | Maintains | Neutral | Get Alert |
| 05/12/2022 | EPIX | Buy Now | ESSA Pharma | $1.61 | 1142.24% | Joseph Catanzaro42% | $50 → $20 | Maintains | Overweight | Get Alert |
| 05/10/2022 | OCUL | Buy Now | Ocular Therapeutix | $7.75 | 106.45% | Joseph Catanzaro42% | $20 → $16 | Maintains | Overweight | Get Alert |
| 05/05/2022 | CNTB | Buy Now | Connect Biopharma Hldgs | $0.85 | 76.49% | Joseph Catanzaro42% | $25 → $1.5 | Downgrade | Overweight → Neutral | Get Alert |
| 03/14/2022 | HARP | Buy Now | Harpoon Therapeutics | — | — | Joseph Catanzaro42% | $270 → $150 | Maintains | Overweight | Get Alert |
| 03/10/2022 | SNSE | Buy Now | Sensei Biotherapeutics | $0.46 | 2073.91% | Joseph Catanzaro42% | $12 → $10 | Maintains | Overweight | Get Alert |
| 03/02/2022 | NLTX | Buy Now | Neoleukin Therapeutics | — | — | Joseph Catanzaro42% | $600 → $500 | Maintains | Overweight | Get Alert |
| 09/08/2021 | AADI | Buy Now | Aadi Bioscience | $2.06 | 2084.47% | Joseph Catanzaro42% | → $675 | Initiates | → Overweight | Get Alert |
| 06/21/2021 | FIGS | Buy Now | FIGS | $4.53 | 672.63% | Joseph Catanzaro42% | → $35 | Initiates | → Overweight | Get Alert |
| 05/20/2021 | IOVA | Buy Now | Iovance Biotherapeutics | $3.59 | 401.39% | Joseph Catanzaro42% | $35 → $18 | Downgrade | Overweight → Neutral | Get Alert |
| 05/18/2021 | RAIN | Buy Now | Rain Oncology | $1.95 | 1182.05% | Joseph Catanzaro42% | → $25 | Initiates | → Overweight | Get Alert |
| 05/11/2021 | HALO | Buy Now | Halozyme Therapeutics | $64.55 | -25.64% | Joseph Catanzaro42% | $50 → $48 | Downgrade | Overweight → Neutral | Get Alert |
| 05/11/2021 | BMEA | Buy Now | Biomea Fusion | $2.59 | 941.87% | Joseph Catanzaro42% | → $27 | Initiates | → Overweight | Get Alert |
| 04/26/2021 | ACHL | Buy Now | Achilles Therapeutics | $1.44 | 1634.91% | Joseph Catanzaro42% | → $25 | Initiates | → Overweight | Get Alert |
| 03/25/2021 | MRKR | Buy Now | Marker Therapeutics | $1.29 | 364.14% | Joseph Catanzaro42% | → $60 | Initiates | → Overweight | Get Alert |
| 03/01/2021 | SNSE | Buy Now | Sensei Biotherapeutics | $0.46 | 5334.78% | Joseph Catanzaro42% | → $25 | Initiates | → Overweight | Get Alert |
| 02/25/2021 | IMAB | Buy Now | I-MAB | $0.84 | 8849.88% | Joseph Catanzaro42% | → $75 | Initiates | → Overweight | Get Alert |
| 02/12/2021 | SGEN | Buy Now | Seagen | — | — | Joseph Catanzaro42% | $175 → $170 | Maintains | Neutral | Get Alert |
| 10/08/2020 | CRDF | Buy Now | Cardiff Oncology | $3.90 | 541.03% | Joseph Catanzaro42% | → $25 | Initiates | → Overweight | Get Alert |
| 08/06/2020 | IMMU | Buy Now | Immunomedics | — | — | Joseph Catanzaro42% | $55 → $60 | Maintains | Overweight | Get Alert |
| 07/24/2020 | SGEN | Buy Now | Seagen | — | — | Joseph Catanzaro42% | $155 → $165 | Downgrade | Overweight → Neutral | Get Alert |
| 07/14/2020 | RPTX | Buy Now | Repare Therapeutics | $1.11 | 3503.6% | Joseph Catanzaro42% | → $40 | Initiates | → Overweight | Get Alert |
| 07/08/2020 | NK | Buy Now | NantKwest | — | — | Joseph Catanzaro42% | → $18 | Initiates | → Overweight | Get Alert |
| 07/02/2020 | HALO | Buy Now | Halozyme Therapeutics | $64.55 | -51.98% | Joseph Catanzaro42% | $28 → $31 | Maintains | Overweight | Get Alert |
| 04/23/2020 | IMMU | Buy Now | Immunomedics | — | — | Joseph Catanzaro42% | $30 → $40 | Maintains | Overweight | Get Alert |
| 04/07/2020 | XBIT | Buy Now | XBiotech | $3.48 | 417.24% | Joseph Catanzaro42% | $28 → $18 | Maintains | Overweight | Get Alert |
| 03/05/2020 | OCUL | Buy Now | Ocular Therapeutix | $7.75 | 41.94% | Joseph Catanzaro42% | $7 → $11 | Reiterates | → Overweight | Get Alert |
| 02/05/2020 | HALO | Buy Now | Halozyme Therapeutics | $64.55 | -58.17% | Joseph Catanzaro42% | $18 → $27 | Upgrade | Neutral → Overweight | Get Alert |
| 12/11/2019 | XBIT | Buy Now | XBiotech | $3.48 | 704.6% | Joseph Catanzaro42% | $16 → $28 | Maintains | Overweight | Get Alert |
| 09/30/2019 | SGEN | Buy Now | Seagen | — | — | Joseph Catanzaro42% | $75 → $95 | Maintains | Overweight | Get Alert |
| 07/17/2019 | SGEN | Buy Now | Seagen | — | — | Joseph Catanzaro42% | $64 → $75 | Upgrade | Neutral → Overweight | Get Alert |
| 06/14/2019 | XBIT | Buy Now | XBiotech | $3.48 | 273.56% | Joseph Catanzaro42% | → $13 | Initiates | → Overweight | Get Alert |
| 04/29/2019 | IOVA | Buy Now | Iovance Biotherapeutics | $3.59 | — | Joseph Catanzaro42% | — | Initiates | → Overweight | Get Alert |
| 11/26/2018 | CTMX | Buy Now | CytomX Therapeutics | $0.66 | — | Joseph Catanzaro42% | — | Initiates | → Overweight | Get Alert |
| 10/19/2018 | IMMU | Buy Now | Immunomedics | — | — | Joseph Catanzaro42% | → $33 | Initiates | → Overweight | Get Alert |
| 09/16/2016 | HALO | Buy Now | Halozyme Therapeutics | $64.55 | -72.11% | Joseph Catanzaro42% | $15 → $18 | Maintains | Overweight | Get Alert |
| 10/30/2015 | SGEN | Buy Now | Seagen | — | — | Joseph Catanzaro42% | $30 → $44 | Upgrade | Underweight → Neutral | Get Alert |
| 08/24/2015 | NK | Buy Now | NantKwest | — | — | Joseph Catanzaro42% | → $38 | Initiates | → Overweight | Get Alert |
| 05/14/2013 | HALO | Buy Now | Halozyme Therapeutics | $64.55 | -84.51% | Joseph Catanzaro42% | → $10 | Initiates | → Overweight | Get Alert |
| 07/02/2012 | SGEN | Buy Now | Seagen | — | — | Joseph Catanzaro42% | $22 → $20 | Downgrade | Neutral → Underweight | Get Alert |
